| ISSN |
1949-8470 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Computed tomography-based nomogram of Siewert type II/III adenocarcinoma of esophagogastric junction to predict response to docetaxel, oxaliplatin and S-1
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chuan-Qinyuan Zhou, Dan Gao, Yan Gui, Ning-Pu Li, Wen-Wen Guo, Hai-Ying Zhou, Rui Li, Jing Chen, Xiao-Ming Zhang and Tian-Wu Chen |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China (General Program) |
82271959 |
| Nanchong-University Cooperative Research Project |
20SXQT0329 |
|
| Corresponding Author |
Tian-Wu Chen, MD, Dean, Director, Doctor, Full Professor, Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, No. 74 Linjiang Road, Yuzhong District, Chongqing 400010, China. tianwuchen_nsmc@163.com |
| Key Words |
Esophagogastric junction; Adenocarcinoma; Neoadjuvant chemotherapy; Response; Tomography; X-ray computed; Predictor |
| Core Tip |
We developed a computed-tomography-based nomogram with independent predictors including cT stage, gross tumor volume and Siewert type to predict the response of Siewert type II/III adenocarcinoma of the esophagogastric junction to neoadjuvant chemotherapy (NAC) with docetaxel, oxaliplatin and S-1 (DOS). The nomogram could predict subgroups of patients who would optimally benefit from NAC with DOS. Siewert type could be a novel predictor for response to NAC compared, which lays a foundation for follow-up studies. |
| Publish Date |
2024-01-23 03:20 |
| Citation |
Zhou CQ, Gao D, Gui Y, Li NP, Guo WW, Zhou HY, Li R, Chen J, Zhang XM, Chen TW. Computed tomography-based nomogram of Siewert type II/III adenocarcinoma of esophagogastric junction to predict response to docetaxel, oxaliplatin and S-1. World J Radiol 2024; 16(1): 9-19 |
| URL |
https://www.wjgnet.com/1949-8470/full/v16/i1/9.htm |
| DOI |
https://dx.doi.org/10.4329/wjr.v16.i1.9 |
